Most notably, all-trans-retinyl acetate sensitized premalignant adenoma cells of APC-deficient mice to TRAIL-induced apoptosis, thus establishing a paradigm for chemoprevention of colon cancer by retinoic acid-TRAIL combination therapy [47]. This evidence concerns the gene TNFSF10 and colonic neoplasm.